Cite
Emergence of a ST248 Pasteur -ST1068 Oxford Carbapenem Resistance Acinetobacter pittii Clinical Isolate in China, Co-Harboring OXA-58 and OXA-500 Carbapenemases.
MLA
Tian, Chongmei, et al. “Emergence of a ST248 Pasteur -ST1068 Oxford Carbapenem Resistance Acinetobacter Pittii Clinical Isolate in China, Co-Harboring OXA-58 and OXA-500 Carbapenemases.” Infection and Drug Resistance, vol. 16, Aug. 2023, pp. 5681–84. EBSCOhost, https://doi.org/10.2147/IDR.S426182.
APA
Tian, C., Song, J., Huang, D., Wang, S., Zhao, Y., Fu, L., Fan, X., Ma, T., & Bai, Y. (2023). Emergence of a ST248 Pasteur -ST1068 Oxford Carbapenem Resistance Acinetobacter pittii Clinical Isolate in China, Co-Harboring OXA-58 and OXA-500 Carbapenemases. Infection and Drug Resistance, 16, 5681–5684. https://doi.org/10.2147/IDR.S426182
Chicago
Tian, Chongmei, Jianqin Song, Delian Huang, Siwei Wang, Yaping Zhao, Liping Fu, Xueyu Fan, Tianhong Ma, and Yongfeng Bai. 2023. “Emergence of a ST248 Pasteur -ST1068 Oxford Carbapenem Resistance Acinetobacter Pittii Clinical Isolate in China, Co-Harboring OXA-58 and OXA-500 Carbapenemases.” Infection and Drug Resistance 16 (August): 5681–84. doi:10.2147/IDR.S426182.